Amphastar Pharmaceuticals (AMPH) Raw Materials (2015 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Raw Materials of $104.7 million for Q1 2026, up 1.37% year-over-year from $103.3 million in Q1 2025, and down 2.03% quarter-over-quarter from $106.8 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Raw Materials (2015 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Raw Materials history runs 12 years deep, the most recent figure standing at $104.7 million for Q1 2026.
- In Q1 2026, Raw Materials rose 1.37% year-over-year to $104.7 million; the TTM figure through Mar 2026 stood at $104.7 million (up 1.37% YoY), while the FY2025 annual figure was $106.8 million, up 31.06% from the prior year.
- Raw Materials for Q1 2026 stood at $104.7 million, down from $106.8 million in the prior quarter.
- The five-year high for Raw Materials was $106.8 million in Q4 2025, with the low at $40.4 million in Q1 2022.
- The 5-year median for Raw Materials is $55.2 million (2023), against an average of $67.9 million.
- The sharpest annual moves came in 2022 and 2025: Raw Materials fell 6.7% in 2022, then jumped 100.84% in 2025.
- Amphastar Pharmaceuticals' Raw Materials stood at $47.6 million in 2022, then climbed by 5.2% to $50.1 million in 2023, then soared by 62.76% to $81.5 million in 2024, then jumped by 31.06% to $106.8 million in 2025, then decreased by 2.03% to $104.7 million in 2026.
- Business Quant data shows AMPH's Raw Materials at $104.7 million in Q1 2026, $106.8 million in Q4 2025, and $105.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Amphastar Pharmaceuticals | 943.15 Mn | 653.02 Mn | 93.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 105.50 Mn |
| Mar 31, 2026 | 104.66 Mn |
| Dec 31, 2025 | 106.83 Mn |
| Sep 30, 2025 | 105.76 Mn |
| Jun 30, 2025 | 106.55 Mn |
| Mar 31, 2025 | 103.25 Mn |
| Dec 31, 2024 | 81.51 Mn |
| Sep 30, 2024 | 60.54 Mn |
| Jun 30, 2024 | 56.44 Mn |
| Mar 31, 2024 | 51.41 Mn |
| Dec 31, 2023 | 50.08 Mn |
| Sep 30, 2023 | 55.18 Mn |
| Jun 30, 2023 | 44.63 Mn |
| Mar 31, 2023 | 47.92 Mn |
| Dec 31, 2022 | 47.61 Mn |
| Sep 30, 2022 | 47.08 Mn |
| Jun 30, 2022 | 43.90 Mn |
| Mar 31, 2022 | 40.36 Mn |
| Dec 31, 2021 | 41.85 Mn |
| Sep 30, 2021 | 45.75 Mn |